Receipt and Storage. 6.1 The Company will:
(a) Receive Grain Delivered at the Facilities during the Term provided that in the sole opinion of the Company the Grain in each case complies with the Receival Standards, is in fit condition for safe and hygienic storage and in the opinion of the Company, storage space permits;
(b) Store the Grain for the Client at the Facilities; and
(c) Outturn the Grain for the Client at such time, or times, and in such quantities as the Client requires in accordance with Clause 7.
6.2 In respect of the Port Terminal only, the Client must, in addition to compliance with all other requirements of this clause 6:
(a) notify the Company that the Client wishes to Deliver Grain to the Port Terminal, including the expected time of Delivery,
(b) obtain the agreement of the Company to Deliver the Grain to the Port Terminal,
(c) Require the Grower to complete an Ex- farm Grower Treatment Declaration available on the Emerald Website.
6.3 The Client will ensure that where a Grain is Delivered by a Grower, or agent on behalf of the Client, the Grower or agent will clearly state in writing the Client’s name at the time of delivery (“Nomination”). The Client will also ensure that a Nomination contains a statement to the effect that the delivering Grower or agent transfers all of the right, title and interest to and in the Grain to the Client. All Nominations are final and irrevocable and the Company may rely on the details of the Nomination without any further enquiries.
6.4 The Client will ensure that where Grain is Delivered from a Non Company Facility, it provides:
(a) written confirmation to the Company of fumigation clearance, and
(b) grain treatment details for the period of time Grain was at a Non Company Facility.
6.5 Unless specifically agreed otherwise, the Company reserves the right to mix the whole or any part of any Grain delivered to it by any client or Growers with Grain of similar specification and any and all such Grains so received will be Stored Grain.
6.6 The Company reserves the right to move Client Grain to a Facility other than the Facility at which the Client acquired the Client Grain if:
(a) sufficient evidence exists to indicate the quality or condition of Grain at a Facility may be adversely affected if the Client Grain remains in any particular location;
(b) the Facility fills to capacity (or is expected to fill to capacity during the Season); or
(c) the Company determines (in the Company’s reasonable opinion) that it is operationally...
Receipt and Storage. 6.1 The Company will:
(a) Receive Grain Delivered at the Facilities during the Term provided that in the sole opinion of the Company the Grain in each case complies with the Receival Standards, is in fit condition for safe and hygienic storage and in the opinion of the Company, storage space permits;
(b) Store the Grain for the Client at the Facilities; and
(c) Outturn the Grain for the Client at such time, or times, and in such quantities as the Client requires in accordance with Clause 7.
6.2 In respect of the Port Terminal only, the Client must, in addition to compliance with all other requirements of this clause 6:
Receipt and Storage. MVA-NP+M1 will be shipped to a distribution centre in the study region. It will then be shipped to the study sites at 2oC to 8oC with a continuous temperature-monitoring device. Upon receipt, the pharmacist or study vaccine manager must immediately inspect all vials for damage. Any damage or discrepancies from the packing list must be documented and promptly discussed with the Sponsor and the Study Monitor to determine the appropriate action. The temperature monitors should be downloaded according to the accompanying instructions in the shipment. Temperature records must be sent to the Local Sponsor and the site will receive written confirmation that the vials are clinically released before they are used. If the temperature monitor has been out of range then the shipment should be placed into quarantine and the Sponsor and Study Monitor contacted immediately to determine whether the study vaccine may be used. Vials of MVA-NP+M1 in the outer carton (to protect from light) must be stored between 2 and 8oC in a continuously monitored refrigerator. The vials of saline placebo will be stored at room temperature. All study treatments must be kept in a secured location with no access for unauthorised personnel. At the start of the study, a sufficient number of MVA-NP+M1 and placebo vials will be shipped to each study site to vaccinate approximately 20% of the planned participants based on recruitment projections. Further study vaccine supplies may be requested following the re- supply process in the Vaccine Management Manual.
Receipt and Storage. Upon receipt of Samples and payment, Saguaro Testing will process Samples and upload Sample information into our laboratory software testing database. Analytical Samples are stored room temperature upon receipt, unless specifically requested otherwise by Client and approved by Saguaro Testing. Storage conditions are based on the nature of the Sample. Samples will be discarded in accordance with Saguaro Testing’s standard operating procedures. Saguaro Testing will retain un-tested Samples in storage for no more than fourteen (14) days, unless longer storage is approved by Saguaro Testing, and Client submits payment of a storage fee, to be determined by Saguaro Testing at the time of approval of such storage request. Client may request that un-tested Samples be re-tested or transferred to another laboratory, provided Saguaro Testing will not be responsible for cost of delivery or transfer of such un-tested Samples. However, Client may request that Saguaro Testing transfer such un-tested Samples to another laboratory for a fee to be determined by Saguaro Testing at the time of Client’s request, which fee must be remitted to Saguaro Testing prior to any such transfer occurring.
Receipt and Storage
